Session » Pediatric Rheumatology – Clinical and Therapeutic Aspects II: Juvenile Arthritis
-
Abstract Number: 2856
Evaluation of a Dosing Regimen for Tocilizumab in Patients Younger Than Two Years of Age with Systemic Juvenile Idiopathic Arthritis
-
Abstract Number: 2857
Short and Long-Term Follow-up of Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis